Related Experiment Video
Updated: Apr 17, 2026

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
Cholesterol management in geriatric patients: new guidelines
Tracy D Mahvan1, Michelle L Hilaire, Ashley Vigil
1University of Wyoming School of Pharmacy, Health Sciences Center, Laramie, Wyoming, USA.
Pharmacists can use the 2013 ACC/AHA cholesterol guidelines to manage hyperlipidemia in older adults. This review covers treatment, monitoring, and adverse effects for geriatric patients on statin therapy.
Area of Science:
- Cardiology
- Geriatric Medicine
- Pharmacology
Background:
- Hypercholesterolemia is a common primary care condition.
- Pharmacists are integral to disease management.
- The 2013 ACC/AHA guidelines offer new treatment recommendations.
Purpose of the Study:
- To review the 2013 ACC/AHA cholesterol guidelines.
- To inform pharmacists on managing hyperlipidemia in the elderly.
- To discuss statin therapy implications for older adults.
Main Methods:
- Review of the 2013 ACC/AHA cholesterol management guidelines.
- Focus on evidence-based recommendations for geriatric care.
- Analysis of implications for statin therapy in older adults.
Main Results:
- The 2013 ACC/AHA guidelines provide specific recommendations for cholesterol management.
- These guidelines impact the use of statin therapy in the elderly.
- The review details monitoring and adverse effects of cholesterol-lowering therapies.
Conclusions:
- Pharmacists are well-positioned to implement the new cholesterol guidelines.
- The guidelines necessitate informed decision-making for geriatric hyperlipidemia management.
- Understanding guideline implications is crucial for optimizing patient outcomes and safety.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Drug Dosing: Geriatric Patients
Angina IV: Management
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Atherosclerosis III: Management

